Update on EGFR-mutated non-small cell lung cancer

Hämta fulltext

CompEx asthma a novel composite exacerbation endpoint /

Hämta fulltext
Series

The evolving role of novel and next generation therapies in the management of multiple myeloma part 1 of 2, introduction and current therapies /

Hämta fulltext

The evolving role of novel and next generation therapies in the management of multiple myeloma part 2 of 2, relapse refractory multiple myeloma /

Hämta fulltext

Clinical trial designs for rare diseases part 1 of 2, trial designs /

Hämta fulltext

Clinical trial designs for rare diseases part 2 of 2, trial protocols /

Hämta fulltext

Research & development of new pharmaceuticals for treatment of endometriosis

Hämta fulltext

Latest developments & future directions in the management of chronic pain

Hämta fulltext
Series

Novel approaches to treating symptoms and slowing the progress of neurodegenerative diseases

Hämta fulltext
Series

Pharmacotherapy for obesity part 1, the need for pharmacotherapy in weight management /

Hämta fulltext

Pharmacotherapy for obesity part 2, pharmacological agents in current use & under development /

Hämta fulltext

The role of exosomes in multiple myeloma development & drug resistance

Hämta fulltext
Series

Pathophysiology and treatment of congestive heart failure in dogs and cats

Hämta fulltext

Recent advancements in the diagnosis and treatment of congestive heart failure in dogs and cats

Hämta fulltext

Nanomedicines for brain diseases

Hämta fulltext
Series

Surrogate endpoints of efficacy

Hämta fulltext
Series

Drug metabolizing enzymes in cancer therapeutics

Hämta fulltext
Series

Cancer treatment paradigms

Hämta fulltext
Series

Antiviral drugs (non-HIV)

Hämta fulltext
Series

Latest development in therapy-related autophagy research

Hämta fulltext
Series